Stocks and Investing
Stocks and Investing
Tue, March 5, 2013
[ 06:00 AM ] - Market Wire
[ 05:45 AM ] - WOPRAI
[ 05:45 AM ] - WOPRAI
[ 05:30 AM ] - Market Wire
[ 04:00 AM ] - Market Wire
[ 03:47 AM ] - WOPRAI
[ 03:47 AM ] - WOPRAI
[ 03:47 AM ] - WOPRAI
[ 03:46 AM ] - WOPRAI
[ 03:46 AM ] - WOPRAI
[ 03:46 AM ] - WOPRAI
[ 03:45 AM ] - WOPRAI
[ 02:46 AM ] - WOPRAI
[ 02:46 AM ] - WOPRAI
[ 02:45 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Schwartz Initiated (SRPT) at Buy and Held Target at $45 on, Mar 5th, 2013
Joseph Schwartz of Leerink Swann, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Buy and Held Target at $45 on, Mar 5th, 2013.
Joseph, nor any peers, have made any analyst calls on SRPT in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30